Aslan Pharmaceuticals Ltd. ADR (ASLN) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Mon November 16th, 2020

- 11:30
  AnalysisASLAN Pharmaceuticals (ASLN) Sees Hammer Chart Pattern: Time to Buy?Zacks

Mon October 19th, 2020

- 14:05
  AnalysisASLAN Pharmaceuticals (ASLN) in Focus: Stock Moves 7% HigherZacks

Sun October 18th, 2020

- 18:53
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDigestWeek In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million DealSeeking Alpha

Mon July 13th, 2020

- 16:00
  RatingAnalysisASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's WhyZacks

Thu June 25th, 2020

- 12:50
  AnalysisASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in SessionZacks

Thu June 11th, 2020

- 16:00
  RatingAnalysisASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's What You Should KnowZacks

SPY$379.40.98%

QQQ$317.871.9%

DOW$57.680.65%

APHA$13.347.4%

BNGO$8.18-3%

GME$38.68.7%

TLRY$19.80.51%

SPY$379.40.98%

QQQ$317.871.9%

DOW$57.680.65%

APHA$13.347.4%

BNGO$8.18-3%

GME$38.68.7%

TLRY$19.80.51%

About Developer Contact